Publications by authors named "J Aberle"

Claim this Profile
O
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial.
Deborah B Horn, Donna H Ryan, Sanja Giljanovic Kis, Breno Alves, Yiming Mu, Jens Aberle

Lancet· December 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tick-borne encephalitis: Burden of disease and impact of vaccination, Austria (2000-2024).
Simon Raffl, David N Springer, Stephan W Aberle, David M Florian, Michael Kundi, Judith H Aberle

Vaccine· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiation of West Nile and Usutu Virus Infections by Antibodies Directed to the Non-Structural Protein 1.
Lena Roßbacher, Samuel Taschler, Elena Cecchettin, Amelie Popovitsch, Stephan W Aberle, Judith H Aberle

Viruses· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohorts.
Adrian Gervais, Francesca Trespidi, Alessandro Ferrari, Francesca Rovida, Astrid Marchal, Judith H Aberle

medRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and associated outcomes of type 2 diabetes mellitus patients with a cardiovascular comorbidity and comparison with guideline recommendations: a German claims data analysis.
Jens Aberle, Daniel Duerschmied, Martin Grond, Michael Lehrke, Stephan Martin

Cardiovasc Diabetol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis